跳至主要内容
临床试验/jRCT1051190043
jRCT1051190043招募中不适用

Safety and efficacy of Budesonide administration after endoscopic balloon dilation for Crohn's disease patients with intestinal stenosis (OGF1707)

未提供0 个研究点目标入组 15 人开始时间: 2018年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
15
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
No limit 至 No limit(—)
性别
All

入选标准

  • Mild to moderate active Crohn's disease patients with written consent at Osaka University Hospital and affiliated hospitals, who have intestinal stenosis and are scheduled or recieved endoscopic balloon dilation (EBD), are included.

排除标准

  • Patients with more than 5 centimeters long stenosis
  • Patients with internal or external fistula
  • Patients with active infection, including abscess
  • Patients with oral treatment of antithrombotic drugs or low platelet that counts less than 50000 per microlitter
  • Patients with cancer
  • Patients under 20 years old
  • Patients with severy bad general condition
  • Patients who are administered steroids within 4 weeks
  • Patients who are judged inapropriate by doctors

结局指标

主要结局

-

Safety within 12 weeks after EBD

次要结局

未报告次要终点

研究者

发起方
未提供

相似试验

Safety and efficacy of Budesonide administration... | 临床试验